Jeffrey Bird
InvestorManaging Director at Bluebird Ventures
Palo Alto, California
Writes $100K β $5M checks Β· typically $1.5M
About
Founder and Managing Director of Bluebird Ventures who previously spent nearly 20 years as a Managing Director at Sutter Hill Ventures investing in early-stage life sciences. He holds a bachelor's degree, MD, and PhD in Cancer Biology from Stanford, and earlier spent 12 years at Gilead Sciences as an early employee rising to SVP Business Operations.
Experience
- Bluebird VenturesManaging Directorcurrent2019 β presentPalo Alto, California, United States
- Sutter Hill VenturesLimited Partnercurrent2021 β present
- Sutter Hill VenturesManaging Directorcurrent2002 β present
- Stanford UniversityMember, Board of Trusteescurrent2026 β presentPalo Alto, CA
- Stanford Health CareBoard Member and Vice Chaircurrent2022 β presentPalo Alto, CA
- Nutcracker TherapeuticsInvestorcurrent2020 β presentBerkeley, California, United States
- EpiriumInvestor and Board Membercurrent2019 β presentSan Diego, California, United States
- Procyrion, Inc.Investor and Board Membercurrent2019 β presentHouston, Texas, United States
- GRAIL, Inc.Investorcurrent2016 β present
- HelixInvestor and Board Membercurrent2015 β present
- Leyden LabsInvestor2022 β 2026Amsterdam, North Holland, Netherlands
- Foresight DxInvestor2020 β 2026Aurora, CO
- Kriya TherapeuticsInvestor2020 β 2026Palo Alto, California, United States
- Teneobio, Inc.Investor and Board Member2017 β 2021
- Portola PharmaceuticalsInvestor and Board Member2005 β 2020
- Forty Seven, Inc.Investor and Lead Director2016 β 2020
- Verinata Health, Inc.CEO2012 β 2013
- IlluminaGM2013
- Gilead SciencesSenior Vice President of Business Operations1998 β 2000
- Gilead SciencesVP Corporate Development, Director Scientific Programs and other1988 β 1998Foster City, CA
Education
- Stanford University School of MedicineMD, Medicine; also Ph.D. Cancer Biology1982 β 1988
- Stanford UniversityBachelor of Science (BS)1978 β 1982
Same school
Also attended Stanford University School of Medicine69
+ 63 more
Also attended Stanford University1,726
+ 1,720 more
Shared employers
Also worked at Stanford University458
+ 452 more
Also worked at Stanford Health Care26
+ 20 more
Also worked at GRAIL, Inc.10
+ 4 more
Also worked at Portola Pharmaceuticals1
Deals Β· 11
Kriya TherapeuticsSolo GP
via Bluebird Ventures Β· filed Jun 2021
EpiriumSolo GP
Forty Seven IncSolo GP
GRAILSolo GP
MedikineSolo GP
NominalSolo GP
Nutcracker TherapeuticsSolo GP
HelixSolo GP
Portola PharmaceuticalsSolo GP
ProcyrionSolo GP
Verinata HealthSolo GP
Attribution from SEC filings, press coverage, and firm rosters. Some rows are inferred. Not right? Tell us.
Network1
Investors connected to Jeffrey in public investor directories β a warm-intro map.












.jpeg)















